Executive Director, Global Commercial Learning & Development
BeiGene
Summary
The Executive Director of Global Learning & Development leads a global commercial learning organization comprising three global centers of excellence (Global Content, Global Sales Capabilities and Global Learning Operations) who will build content and capabilities to support the BeOne Commercial organizations across the regions. This position will partner with the regional training teams across North America, China, EMEA, and JAPAC, responsible for developing enterprise commercial capabilities and enabling consistent execution across BeOne's global commercial organization.
Job description
Position Summary
The Executive Director, Global Commercial Learning & Development is responsible for building the commercial capabilities that enable BeOne's global commercial organization to successfully launch, grow, and maximize the value of our portfolio. Reporting to the Vice President, Global Business Planning & Operations, this leader, in partnership with the regions, will establish and execute a global commercial learning strategy that develops world-class capabilities across product knowledge, disease state expertise, selling excellence, leadership, coaching, and launch readiness.
Key Responsibilities
Establish the Global Commercial Learning Strategy
- Develop and execute a comprehensive global commercial learning strategy in partnership with the regions aligned with corporate and commercial priorities.
- Build a scalable global learning operating model that enables content to be developed centrally and customized locally.
- Establish enterprise learning frameworks, guiding principles, and best practices in partnership with regional Commercial Learning leaders.
- Establish a multi-year roadmap that supports BeOne's expanding oncology portfolio and global commercial growth.
Build Commercial Capabilities
- Product and disease-state education
- Launch readiness curricula
- Global onboarding programs
- Selling excellence methodology
- Coaching model
- Leadership development for commercial managers
- Market Access capabilities
- Business acumen
- Customer engagement capabilities
- Ensure learning solutions evolve alongside portfolio expansion and changing customer needs
Lead Global Curriculum Development
- Existing commercial brands
- Pipeline launches
- New indications
- Competitive landscape updates
- Clinical data updates
- Market access evolution
- Partner closely with Global Marketing, Medical Affairs and other functions to ensure scientific accuracy, commercial relevance and consistent messaging
Lead the Global Learning Organization
- Global curriculum teams
- Learning Operations
- Instructional Design
- Partner closely with regional Commercial Learning Leads
- Build a collaborative culture across regions that leverages global scale while respecting local market requirements
- Develop organizational capabilities, succession plans, and talent across the learning organization
Drive Learning Innovation
- Digital learning platforms
- AI-enabled coaching
- Simulation-based learning
- Microlearning
- Social learning
- Advanced learning analytics
- Continuously evaluate emerging technologies and learning methodologies that improve learner engagement and business outcomes
Learning Operations & Technology
- Learning Management Systems
- Learning technologies
- Vendor management
- Budget management
- Instructional design resources
- Learning analytics
- Global learning standards
- Drive operational excellence through standardized processes, efficient resource utilization, and global governance
Measure Business Impact
- Time to productivity
- Launch readiness
- Capability assessments
- Sales competency
- Coaching effectiveness
- Learner engagement
- Commercial performance indicators
- Use analytics and feedback to continuously improve learning solutions and demonstrate business value
Qualifications
Required Experience: Bachelor's degree required; advanced degree preferred. 15+ years of progressive leadership experience within the pharmaceutical or biotechnology industry. Significant experience leading commercial learning, sales capability, commercial excellence, or field effectiveness organizations. Demonstrated success leading global, matrixed organizations across multiple geographies. Experience supporting global product launches and lifecycle commercialization. Proven ability to build organizational capabilities and lead transformational change.
Leadership Competencies
- Enterprise mindset
- Strategic thinking
- Strong business and commercial acumen
- Exceptional influencing skills
- Organizational leadership
- Ability to lead through complexity and ambiguity
- Executive presence
- Talent development and coaching
- Strong collaboration across functions and regions
- Continuous improvement mindset
Requirements
- Bachelor's degree required
- Advanced degree preferred
- 15+ years of progressive leadership experience within the pharmaceutical or biotechnology industry
- Significant experience leading commercial learning, sales capability, commercial excellence, or field effectiveness organizations
- Demonstrated success leading global, matrixed organizations across multiple geographies
- Experience supporting global product launches and lifecycle commercialization
- Proven ability to build organizational capabilities and lead transformational change
- Enterprise mindset
- Strategic thinking
- Strong business and commercial acumen
- Exceptional influencing skills
- Organizational leadership
- Ability to lead through complexity and ambiguity
- Executive presence
- Talent development and coaching
- Strong collaboration across functions and regions
- Continuous improvement mindset
Benefits
- Medical, Dental & Vision
- 401(k)
- FSA/HSA
- Life Insurance
- Paid Time Off
- Wellness
- Incentive Compensation Plan
- Discretionary Equity Awards
- Employee Stock Purchase Plan
Company overview
BeiGene, Ltd., now rebranding as BeOne Medicines, is a global commercial-stage biotechnology company specializing in the discovery, development, manufacturing, and commercialization of innovative oncology medicines. Founded in 2010 by John V. Oyler and Xiaodong Wang, the company has grown into a multinational organization with headquarters in Cambridge, Massachusetts, Beijing, China, and Basel, Switzerland. BeiGene focuses on developing targeted and immune-oncology therapies for cancer treatment, with a diverse pipeline that includes internally discovered products like BRUKINSA (zanubrutinib), a Bruton's tyrosine kinase inhibitor, and Tevimbra (tislelizumab), a PD-1 inhibitor. The company operates across six continents with over 45 countries participating in clinical trials and has enrolled more than 30,000 patients in its research programs. With approximately 12,000 employees worldwide, BeiGene has established itself as a significant player in global oncology, particularly with strong market presence in China and expanding operations in the United States and Europe. The company's mission centers on expanding access to high-quality cancer therapies worldwide through persistent innovation and challenging traditional approaches to drug development.